Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Compérat

Showing results (31-40 of 242) with videos related to

Pageof 25
Sort By:
European Urology|July 28, 2019
Reply re: Murali Varma, Brett Delahunt, Theodorus van der Kwast. Grading Noninvasive Bladder Cancer: World Health Organisation 1973 or 2004 May Be the Wrong Question. Eur Urol 2019;76:413-5: Two Decades of World Health Organisation/International Society of Urological Pathology Bladder Cancer Grading: Time to Reflect on Accomplishments and Plan Refinement in the Molecular Era, Not Regress to Readoption of a 45-year-old ClassificationEva Compérat, Mahul Amin, Victor Reuter
Annales De Pathologie|June 12, 2004
[Late metastasis after a testicular Sertoli cell tumour]Eva Compérat, Fréderique Tissier, Annick Vieillefond
European Urology|August 18, 2024
Re: Metastasis and Recurrence Patterns in the Molecular Subtypes of Urothelial Bladder CancerEva Compérat, Gabriel Wasinger, Johannes Kläger
Annales De Pathologie|January 31, 2004
[Gastrointestinal bleeding: a difficult diagnosis]Eva Compérat, Pierre Balladur, Jean-François Fléjou
Annales De Pathologie|August 20, 2013
[Benign mimickers of the prostate cancer. Diagnostic challenges]Eva Compérat, Justine Varinot, John R Srigley
Histopathology|November 8, 2023
Head-to-head: how many categories for grading urothelial carcinoma?Murali Varma, Eva Compérat, Theodorus van der Kwast
Annales De Pathologie|October 22, 2008
[Prospects 2007 in vesical pathology. Introduction]Yves Allory, Eva Compérat, Catherine Mazerolle, et al.
Virchows Archiv : an International Journal of Pathology|May 10, 2017
HOXB13 a useful marker in pleomorphic giant cell adenocarcinoma of the prostate: a case report and review of the literatureLaura Larnaudie, Eva Compérat, Pierre Conort, et al.
The Journal of Molecular Diagnostics : JMD|March 20, 2024
Panel Comparative Analysis Tool: An Open-Source Comparative Analysis Tool for Next-Generation Sequencing Panel Target RegionsAndré Oszwald, Lucia Zisser, Eva Compérat, et al.
Aktuelle Urologie|March 28, 2018
[The role of biomarkers in the diagnosis, prognosis and therapy of patients with immuno-oncological treatments of genito-urinary carcinomas]Eva Compérat, Caroline Eymerit, Julien Moroch, et al.
Pageof 25

Showing results (31-40 of 242) with videos related to

Sort By:
Pageof 25
European Urology|July 28, 2019
Reply re: Murali Varma, Brett Delahunt, Theodorus van der Kwast. Grading Noninvasive Bladder Cancer: World Health Organisation 1973 or 2004 May Be the Wrong Question. Eur Urol 2019;76:413-5: Two Decades of World Health Organisation/International Society of Urological Pathology Bladder Cancer Grading: Time to Reflect on Accomplishments and Plan Refinement in the Molecular Era, Not Regress to Readoption of a 45-year-old ClassificationEva Compérat, Mahul Amin, Victor Reuter
Annales De Pathologie|June 12, 2004
[Late metastasis after a testicular Sertoli cell tumour]Eva Compérat, Fréderique Tissier, Annick Vieillefond
European Urology|August 18, 2024
Re: Metastasis and Recurrence Patterns in the Molecular Subtypes of Urothelial Bladder CancerEva Compérat, Gabriel Wasinger, Johannes Kläger
Annales De Pathologie|January 31, 2004
[Gastrointestinal bleeding: a difficult diagnosis]Eva Compérat, Pierre Balladur, Jean-François Fléjou
Annales De Pathologie|August 20, 2013
[Benign mimickers of the prostate cancer. Diagnostic challenges]Eva Compérat, Justine Varinot, John R Srigley
Histopathology|November 8, 2023
Head-to-head: how many categories for grading urothelial carcinoma?Murali Varma, Eva Compérat, Theodorus van der Kwast
Annales De Pathologie|October 22, 2008
[Prospects 2007 in vesical pathology. Introduction]Yves Allory, Eva Compérat, Catherine Mazerolle, et al.
Virchows Archiv : an International Journal of Pathology|May 10, 2017
HOXB13 a useful marker in pleomorphic giant cell adenocarcinoma of the prostate: a case report and review of the literatureLaura Larnaudie, Eva Compérat, Pierre Conort, et al.
The Journal of Molecular Diagnostics : JMD|March 20, 2024
Panel Comparative Analysis Tool: An Open-Source Comparative Analysis Tool for Next-Generation Sequencing Panel Target RegionsAndré Oszwald, Lucia Zisser, Eva Compérat, et al.
Aktuelle Urologie|March 28, 2018
[The role of biomarkers in the diagnosis, prognosis and therapy of patients with immuno-oncological treatments of genito-urinary carcinomas]Eva Compérat, Caroline Eymerit, Julien Moroch, et al.
Pageof 25